Here Are The 298 Costliest Rules In The New Unified Agenda Of Federal Regulations forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
[1] the HHS Office of Inspector General (OIG) said Visiting Nurse Association of Maryland (VNA) received overpayments of $2.1 million in 2015 and 2016. OIG audited a stratified random sample of 100 claims and found errors on 19 of them. As a result, VNA received overpayments of $25,295 for services provided in 2015 and 2016. “On the basis of our sample results, we estimated that VNA received overpayments of at least $2.1 million for the audit period,” according to OIG, which noted all the claims are outside the reopening period. OIG said VNA billed for services provided to beneficiaries who weren’t homebound or delivered services that were inconsistent with the plan of care, among other errors. VNA disagreed with most of OIG’s findings. In a letter to OIG, the home health agency said, “VNA stands firm that it was providing covered services,” and “the error rate does not support extrapolation.”
Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below.
I. Regulations, Notices & Guidance
On April 26, 2021, the Food and Drug Administration (FDA) issued guidance entitled,
Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases; Draft Guidance for Sponsor-Investigators. FDA is publishing this draft guidance to help sponsor-investigators with developing the nonclinical information that FDA recommends to support an investigational new drug application (IND) for certain individual
Thursday, March 11, 2021
On March 10, 2021, Congress finalized and passed the American Rescue Plan of 2021 (ARP), the latest COVID-19 relief package that largely tracks President Biden’s initial $1.9 trillion proposal. The ARP extends unemployment insurance benefits and provides direct $1,400 stimulus payments to qualifying Americans, but it also makes several important health-policy-related changes. These include providing funding for vaccine distribution and testing to combat the COVID-19 pandemic, making policy adjustments to the Medicaid program, facilitating health insurance coverage and providing more money for healthcare providers. The final bill also makes two narrowly focused technical Medicare payment changes.
In developing and finalizing the bill, Democrats used the budget reconciliation process to pass the bill with only Democratic support. This process limited what could be included. The version that was signed into law ultimately removed a provision to inc
A Chronology of COVID-19 Relief for ERISA Plans
In 2020, the employee benefits world was dominated by the COVID-19 pandemic. The following chronology highlights the ongoing relief provided by legislation, regulatory action, and other agency guidance to assist ERISA plan participants, fiduciaries, and sponsors during the ongoing COVID-19 pandemic through November 30, 2020. (Superseded agency guidance has been omitted.) We provide a number of links to articles on our blog, Benefits Law Update, which offer additional information about many of these important regulatory changes.
Much of the guidance is temporary, with effects limited to 2020. However, with the pandemic and the declared national emergency extending into 2021, we anticipate that some of these measures will be renewed or extended, and similar relief may be offered in the year to come.